skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

GMC is criticised for investments in Nestlé and McDonald’s

BMJ (Online), 2023-03, Vol.380, p.580-580 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2023BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.p580 ;PMID: 36921923

Full text available

Citations Cited by
  • Title:
    GMC is criticised for investments in Nestlé and McDonald’s
  • Author: MacDonald, Ronald
  • Subjects: Accountability ; Fast food ; Fast Foods ; Food ; Health care ; Humans ; Hygiene ; Ice cream ; Investments ; Medical equipment ; News ; Obesity ; Public health ; Restaurants ; Robotic surgery ; Soft drinks ; Transparency
  • Is Part Of: BMJ (Online), 2023-03, Vol.380, p.580-580
  • Description: A freedom of information request showed that it has investments totalling nearly £870 000 (€985m; $1.05m) in the food and soft drink companies Nestlé, McDonald’s, Starbucks, PepsiCo, Coca-Cola, and Unilever, which owns the ice cream brands Magnum, Wall’s, and Ben & Jerry’s. The GMC also invested more than £1.2m in drug companies, including Novo Nordisk, AstraZeneca, Merck, and Roche, more than £470 000 in private insurance or healthcare providers such as Humana Health and UnitedHealth Group, and more than £1.3m in medical device manufacturers, including Edwards Lifesciences, Thermo Fisher Scientific, and Intuitive Surgical, the makers of the da Vinci robotic surgical system (box 1).Box 1 Some of GMC’s direct investments as at end of January 2023 Fast food Nestlé McDonald’s Coca-Cola PepsiCo Starbucks Unilever (owner of Magnum, Wall’s, and Ben & Jerry’s ice creams) Pharma Abbott Labs AstraZeneca ICON Merck Novo Nordisk Roche Zoetis Medical devices Danaher Edwards Lifesciences Illumina Intuitive Surgical (makers of Da Vinci) Medtronic Stryker Thermo Fisher Scientific Private healthcare Humana UnitedHealth Group The GMC, which charges doctors £161 as a one-off registration fee and then £420 in ongoing annual fees, invests its money through Churches, Charities and Local Authorities Investment Management (CCLA). Lack of transparency Doctors have criticised the investments because of the link between fast food and soft drink companies’ products and rising rates of obesity worldwide and because the investments are not published on the GMC’s website.1 Martin McKee, professor of European public health at the London School of Hygiene and Tropical Medicine, said, “Many doctors whose work involves dealing with the harms caused by junk food marketing would, if they knew, despair at how their money is being invested.
  • Publisher: England: British Medical Journal Publishing Group
  • Language: English
  • Identifier: ISSN: 1756-1833
    EISSN: 1756-1833
    DOI: 10.1136/bmj.p580
    PMID: 36921923
  • Source: AUTh Library subscriptions: ProQuest Central
    MEDLINE
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait